Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A standardized nomenclature design for systematic referencing and identification of animal cellular material

  • Schrade, Lisa
  • Mah, Nancy
  • Bandrowski, Anita
  • Chen, Ying
  • Dewender, Johannes
  • Diecke, Sebastian
  • Hiepen, Christian
  • Lancaster, Madeline A.
  • Marquès i Bonet, Tomàs, 1975-
  • Martínez, Sira
  • Mueller, Sabine C.
  • Navara, Christopher
  • Prigione, Alessandro
  • Seltmann, Stefanie
  • Sochacki, Jaroslaw
  • Sutcliffe, Magdalena A.
  • Zywitza, Vera
  • Hildebrandt, Thomas B.
  • Kurtz, Andreas
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research., This work was supported by the Horizon Europe Programme (projects “hPSCreg” #101074135 and “SIMPATHIC” #101080249), the German Federal Ministry of Education and Research (BMBF) (projects “BioRescue” #16LW0187K and #16LW0188; and #01GM2002A), the German Research Foundation (DFG) (#PR1527/5-1 and #PR1527/6-1) and the European Joint Programme for Rare Diseases (EJPRD).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Standardized Nomenclature Design for Systematic Referencing and Identification of Animal Cellular Material

  • Schrade, Lisa
  • Mah, Nancy
  • Bandrowski, Anita
  • Chen, Ying
  • Dewender, Johannes
  • Diecke, Sebastian
  • Hiepen, Christian
  • Lancaster, Madeline A.
  • Marqués-Bonet, Tomàs
  • Martínez, Sira
  • Mueller, Sabine C.
  • Navara, Christopher
  • Prigione, Alessandro
  • Seltmann, Stefanie
  • Sochacki, Jaroslaw
  • Sutcliffe, Magdalena A.
  • Zywitza, Vera
  • Hildebrandt, Thomas B.
  • Kurtz, Andreas
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research., This work was supported by the Horizon Europe Programme (projects “hPSCreg” #101074135 and “SIMPATHIC” #101080249), the German Federal Ministry of Education and Research (BMBF) (projects “BioRescue” #16LW0187K and #16LW0188; and #01GM2002A), the German Research Foundation (DFG) (#PR1527/5-1 and #PR1527/6-1) and the European Joint Programme for Rare Diseases (EJPRD)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology

  • Karnebeek, Clara D. M. van
  • Müller, Annelieke R.
  • Benkemoun, Laura
  • Boussaad, Ibrahim
  • Cornel, Martina C.
  • IntHout, Joanna
  • Kort, Martin de
  • Martins, Sofia de Oliveira
  • Prigione, Alessandro
  • Rigter, Tessel
  • Roes, Kit C. B.
  • Sánchez, Anna
  • Schipper, Raymond
  • Wilkinson, Mark D.
  • Hoen, Peter A.Chr 't
Rare diseases affect over 400 million people worldwide, with approved treatment available for less than 6 % of these diseases. Drug repurposing is a key strategy in the development of therapies for rare disease patients with large unmet medical needs. The process of repurposing drugs compared to novel drug development is a time-saving and cost-efficient method potentially resulting in higher success rates. To accelerate and ensure sustainability in therapy development for rare neurometabolic, neurological, and neuromuscular diseases, an international consortium SIMilarities in clinical and molecular PATHology (SIMPATHIC) has been established where we move away from the one drug one disease concept and move towards one drug targeting a pathomechanism shared between diseases, by applying parallel preclinical and clinical drug development. Here the consortium describes accelerators of drug repurposing pursued by the consortium, including 1) co-creation, 2) patient empowerment, 3) use of standardized induced pluripotent stem cell (iPSC)-derived disease models and cellular and molecular profiling, 4) high-throughput drug screening in neurons, 5) innovative clinical trial design, and 6) selection of appropriate exploitation and patient access models. In this way, a fast and effective drug repurposing pathway for several rare diseases will be established to reduce time from discovery to patient access., SIMPATHIC is funded by the European Commission's Horizon Europe Programme under grant no. 101080249. AM salary is funded via the ministry of Education, Culture and Science in The Netherlands., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids

  • Menacho, Carmen
  • Okawa, Satoshi
  • Álvarez-Merz, Iris
  • Wittich, Annika
  • Muñoz-Oreja, Mikel
  • Lisowski, Pawel
  • López Martín, Mario
  • Pentimalli, Tancredi Massimo
  • Zakin, Shiri
  • Thevandavakkam, Mathuravani
  • Jerred, Caleb
  • Lickfett, Selene
  • Petersilie, Laura
  • Rybak-Wolf, Agnieszka
  • Seibt, Annette
  • Herebian, Diran
  • Inak, Gizem
  • Brodesser, Susanne
  • Zaliani, Andrea
  • Mlody, Barbara
  • Donnelly, Justin
  • Woleben, Kasey
  • Soriano, Francesc Xavier
  • Fernández-Checa, José C.
  • Ventura, Natascia
  • Cambridge, Sidney
  • Mayatepek, Ertan
  • Spinazzola, Antonella
  • Schuelke, Markus
  • Rajewsky, Nikolaus
  • Rossi, Andrea
  • Peralvarez-Marin, Alex
  • Distelmaier, Felix
  • Perlstein, Ethan
  • Holt, Ian J.
  • Puighermanal, Emma
  • Pless, Ole
  • Rose, Christine R.
  • Del Sol, Antonio
  • Prigione, Alessandro
Leigh syndrome (Leigh) is an untreatable mitochondrial disorder characterized by lactic acidosis and basal ganglia and midbrain pathology, leading to psychomotor regression and early death. We previously uncovered impaired neuronal morphogenesis in Leigh cerebral organoids carrying SURF1 gene variants. Leveraging this phenotype, we here develop a deep learning algorithm tailored for cell type-specific drug repurposing screening. In parallel, we perform a survival drug screen in a yeast model of Leigh. The two approaches independently converge on azole compounds, two of which - talarozole and sertaconazole - rescue neuronal morphogenesis in Leigh neurons and lower lactate release and improve growth rate in Leigh midbrain organoids. Mechanistically, these compounds modulate the retinoic acid pathway and membrane-associate lipid metabolism. The findings highlight azoles as promising candidates for Leigh and demonstrate the potential of combining in silico screens with human brain organoids as new approach methodologies (NAMs) to advance the discovery of therapeutics addressing rare neurodevelopmental disorders., Open Access funding enabled and organized by Projekt DEAL. We thank Jens Schwamborn (Luxembourg University) and his group for providing their published MO datasets. We acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) (PR1527/5-1, PR1527/6-1, PR1527/15-1, PR1527/14-1, and PR1527/13-1 to A.P.; RO5380/1-1 to A.R.; Ro2327/13-2 to C.R.R.; AL2956/1-1 to I.A-M.; VE366/12-1 to N.V.), the European Joint Programme on Rare Diseases (EJP RD) and Federal Ministry of Research, Technology and Space (BMFTR) (CureMILS #01GM2002A to A.P., #01GM2002B to O.P.), the Medical Faculty of Heinrich Heine University (FoKo grant to A.P. and S.C.), the European Commission’s Horizon Europe Programme (SIMPATHIC #101080249 to A.P. and M.S.), AFM-Téléthon (SildeMITO #28545 to A.P. and M.S.; GenT-Leigh #29044 to A.P.), the United Mitochondrial Disease Foundation (UMDF) and the Leigh Syndrome International Consortium (LSIC) (to A.P.), People Against Leigh syndrome (PALS) (to A.P.), the Foundation Maladies Rare and Association (AMMi) (to A.P.), the patient organizations Mitocon, Cure Mito, Cure ATP6, Mito Foundation, and MitoHelp (to A.P.), and the Eva Luise Köhler Foundation (to A.P. and M.S.), the Studienstiftung des deutschen Volkes (to S.L.), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGUAR) Generalitat de Catalunya through the Indústria del Coneixement LLAVOR program (grant 2024 LLAV 00069 to E.Pu.), National Science Center OPUS (#2017/27/B/NZ1/02401 to P.L.), and funds from MICINN (PID2021-125079OA-I00 to E.Pu.). A.Sp. and I.J.H. receive research support from the UK Medical Research Council (MR/X002365/1), Muscular Dystrophy UK (17GRO-PG24-0184-1), and the CHAMP Foundation. A.Sp. is the recipient of a Miriam Marks Senior Fellowship, Brain Research UK (202021-26) and receives funds from the Lily Foundation. I.J.H. is supported by grants from the Instituto de Salud Carlos III PI20/00096, the Spanish Ministry of Science, PID2023-151649NB-I00, and the Basque Government Department of Health (Osasun Saila, Eusko Jaurlaritzako) (grants 2021111070; 2022333050; 2018111043; 2018222031). M.M.O. was partially supported by the Ikerbasque, Basque Foundation for Science IKUR strategy, Neurodegenprot project. S.L. was supported by the Studienstiftung des deutschen Volkes. J.F-C acknowledges support from the MICINN (PID2022-142956OB-100 and PID2025-173094OB-I00), the National Cancer Institute PO1 CA281819-O1A1 from the NIH, and the CIBEREHD and the European Horizon´s research and Innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement #101095679). We are grateful to Anje Sporbert (Advanced Light Microscopy, MDC, Berlin) for help with the mitochondrial movement recordings and acknowledge the Center for Advanced Imaging (CAi) at Heinrich Heine University Düsseldorf for providing access to the PerkinElmer Operetta CLS (DFG grant # INST 208/760-1 FUGG) and Olympus FV3000 microscope., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A standardized nomenclature design for systematic referencing and identification of animal cellular material

  • Schrade, Lisa
  • Mah, Nancy
  • Bandrowski, Anita
  • Chen, Ying
  • Dewender, Johannes
  • Diecke, Sebastian
  • Hiepen, Christian
  • Lancaster, Madeline A.
  • Marquès i Bonet, Tomàs, 1975-
  • Martínez, Sira
  • Mueller, Sabine C.
  • Navara, Christopher
  • Prigione, Alessandro
  • Seltmann, Stefanie
  • Sochacki, Jaroslaw
  • Sutcliffe, Magdalena A.
  • Zywitza, Vera
  • Hildebrandt, Thomas B.
  • Kurtz, Andreas
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research., This work was supported by the Horizon Europe Programme (projects “hPSCreg” #101074135 and “SIMPATHIC” #101080249), the German Federal Ministry of Education and Research (BMBF) (projects “BioRescue” #16LW0187K and #16LW0188; and #01GM2002A), the German Research Foundation (DFG) (#PR1527/5-1 and #PR1527/6-1) and the European Joint Programme for Rare Diseases (EJPRD).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Standardized Nomenclature Design for Systematic Referencing and Identification of Animal Cellular Material

  • Schrade, Lisa
  • Mah, Nancy|||0000-0002-1240-8076
  • Bandrowski, Anita|||0000-0002-5497-0243
  • Chen, Ying|||0000-0001-5770-6133
  • Dewender, Johannes|||0000-0002-8711-6203
  • Diecke, Sebastian|||0000-0002-5219-5992
  • Hiepen, Christian|||0000-0001-7345-6496
  • Lancaster, Madeline A.|||0000-0003-2324-8853
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Martinez, Sira|||0000-0002-6642-4514
  • Mueller, Sabine C.|||0000-0001-5184-1254
  • Navara, Christopher|||0000-0001-5915-0327
  • Prigione, Alessandro|||0000-0001-9457-1952
  • Seltmann, Stefanie|||0000-0002-8411-3226
  • Sochacki, Jaroslaw|||0000-0002-4599-9490
  • Sutcliffe, Magdalena A.|||0000-0001-5853-2331
  • Zywitza, Vera|||0000-0003-3055-8569
  • Hildebrandt, Thomas B.|||0000-0001-8685-4733
  • Kurtz, Andreas|||0000-0003-3301-6546
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research.